An activating immunoreceptor complex formed by NKG2D and DAP10
about
Human NKG2D-ligands: cell biology strategies to ensure immune recognitionCostimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cellsA DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cellsBinding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICAThe structural basis for intramembrane assembly of an activating immunoreceptor complexHuman cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicityThe structure of the zetazeta transmembrane dimer reveals features essential for its assembly with the T cell receptorRegulation of immune cell function and differentiation by the NKG2D receptorCell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2DNTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative diseaseDAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cellsComparative genomics of natural killer cell receptor gene clusters.Signaling in Effector Lymphocytes: Insights toward Safer ImmunotherapyNKG2D ligands as therapeutic targetsRemodelling of cortical actin where lytic granules dock at natural killer cell immune synapses revealed by super-resolution microscopyRemote control of therapeutic T cells through a small molecule-gated chimeric receptor.Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 AStructure of the HCMV UL16-MICB Complex Elucidates Select Binding of a Viral Immunoevasin to Diverse NKG2D LigandsThe Immunomodulatory Functions of Diacylglycerol Kinase ζNKG2D Ligands in Tumor Immunity: Two Sides of a CoinCEACAM1 on activated NK cells inhibits NKG2D-mediated cytolytic function and signalingSpecific heteromeric association of four transmembrane peptides derived from platelet glycoprotein Ib-IX complexNKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathwayOsteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient miceA novel cluster of lectin-like receptor genes expressed in monocytic, dendritic and endothelial cells maps close to the NK receptor genes in the human NK gene complexNKG2D recruits two distinct adapters to trigger NK cell activation and costimulationSelective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2DA one year follow-up study of natural killer and dendritic cells activities in multiple sclerosis patients receiving glatiramer acetate (GA)Dendritic cell immunoactivating receptor, a novel C-type lectin immunoreceptor, acts as an activating receptor through association with Fc receptor gamma chainExpression and functional role of MDL-1 (CLEC5A) in mouse myeloid lineage cellsContrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer CellsNatural killer cell differentiation driven by Tyro3 receptor tyrosine kinasesSignal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12A role for the ITAM signaling module in specifying cytokine-receptor functionsGenetic Diversity and mRNA Expression of Porcine MHC Class I Chain-Related 2 (SLA-MIC2) Gene and Development of a High-Resolution Typing MethodUp on the tightrope: natural killer cell activation and inhibitionRegulation of NK cell repertoire and function in the liver.CD8+T cell-specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8+T cell accumulation in tumorsTransfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function.The traffic of the NKG2D/Dap10 receptor complex during natural killer (NK) cell activation
P2860
Q21131219-4A84F8A7-0C9B-4987-A900-4785BC2E0F19Q24290869-F6E41C29-8EEC-4ECE-82DF-64BB63C610E0Q24291798-24F535B6-050B-4337-8867-A9B9311B416DQ24292262-A4A9CBD1-8069-476D-9807-5A699D612FD4Q24301707-BC32EECE-C539-41ED-B222-0BC787CBC576Q24303742-FBA45B11-0635-4C38-AAD5-767999E270B2Q24307955-7D9AA41D-37FD-4F7A-90D3-D1DB695AB56EQ24635093-E15D95C5-34EA-410A-AC04-705170ADD08AQ24647598-8F111660-41AC-411F-87D6-DC20929D949FQ24675566-9FA258D3-C2CF-4FD1-9B85-E32C64A50A56Q24675903-B151AA2D-05D5-438F-98BB-84EE45B7B891Q24816578-17014459-509D-4094-9682-6B35B9012417Q26744654-C8B237BD-E143-4C33-84FC-DF8D945A595EQ27014888-BD8770DD-53D5-4CA0-A573-79311AC665D7Q27320914-0874C5DD-C10F-4B92-BD7C-5302E04B0CB0Q27330599-8633ABAE-0BD8-4717-AC08-16926C2FA10EQ27630065-2BEDFCF1-190B-4AC9-B9AF-B262F71762C7Q27659082-B7BFC55F-D6C5-4E5F-8F3E-FA1B5B58390CQ28069781-F0C932FD-1558-4DCA-BC2B-E8562662AA62Q28083832-1F31B90F-8B2E-4CB6-936D-362E5C50584CQ28115742-456B6B59-0473-403B-AD5F-969127D18421Q28116998-D64CB395-4E1B-4FD8-8852-58A31E1DA207Q28203601-8C9C69E7-80BC-420D-95DA-66535F056532Q28207641-C18FE786-8AA0-4D44-8D15-93075483A948Q28211474-8EC09405-90BD-4C1C-A68D-532D1ED456C6Q28214524-AC76E002-EFDA-406D-8C4C-EA3B7FBF3421Q28214530-FE49C6E8-BEF2-4EF7-9A1B-C9596CDDBE4BQ28486389-77CF2C3A-31A8-413C-9D12-776F38381FD4Q28509885-BF54F4D0-5B6B-494F-85C5-34CCBC917453Q28511564-41192239-0E4F-4209-9762-0985F5300E3AQ28550076-B7A3AEEA-D166-4139-95D8-A85746322C3CQ28587024-9B73E98D-2F88-4A59-9BDE-D08D61D84DF9Q28590300-490E249D-A3A4-4CF5-BD41-943014F02480Q28592321-324DFC92-5FEA-4BB3-B3B2-C3360ED38BEAQ28608464-C42DD795-66BF-45BB-BBFC-A5678C2FE9A6Q29619175-9A8F266D-B827-4529-BF21-70F9E95EABB0Q30430960-27A3A6AD-2FF4-4822-9BA8-F6B8AD34B6C1Q30442426-943C8E86-DD2F-4991-BBD4-9BB2C47F7002Q30477811-2DD282C2-3359-49CD-9A9B-0FF7EFC50BBAQ30488939-E586D93A-FB1F-48A5-B772-916A7A32F1ED
P2860
An activating immunoreceptor complex formed by NKG2D and DAP10
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
An activating immunoreceptor complex formed by NKG2D and DAP10
@ast
An activating immunoreceptor complex formed by NKG2D and DAP10
@en
An activating immunoreceptor complex formed by NKG2D and DAP10
@en-gb
An activating immunoreceptor complex formed by NKG2D and DAP10
@nl
type
label
An activating immunoreceptor complex formed by NKG2D and DAP10
@ast
An activating immunoreceptor complex formed by NKG2D and DAP10
@en
An activating immunoreceptor complex formed by NKG2D and DAP10
@en-gb
An activating immunoreceptor complex formed by NKG2D and DAP10
@nl
prefLabel
An activating immunoreceptor complex formed by NKG2D and DAP10
@ast
An activating immunoreceptor complex formed by NKG2D and DAP10
@en
An activating immunoreceptor complex formed by NKG2D and DAP10
@en-gb
An activating immunoreceptor complex formed by NKG2D and DAP10
@nl
P2093
P921
P3181
P1433
P1476
An activating immunoreceptor complex formed by NKG2D and DAP10
@en
P2093
A B Bakker
J H Phillips
L L Lanier
P3181
P356
10.1126/SCIENCE.285.5428.730
P407
P577
1999-07-30T00:00:00Z